Premia Real Estate Investment Company Societe Anonyme Future Growth
Future criteria checks 1/6
Premia Real Estate Investment Company Societe Anonyme's earnings are forecast to decline at 7.2% per annum while its annual revenue is expected to grow at 15.3% per year.
Key information
-7.2%
Earnings growth rate
n/a
EPS growth rate
| Real Estate earnings growth | 97.9% |
| Revenue growth rate | 15.3% |
| Future return on equity | 10.2% |
| Analyst coverage | Low |
| Last updated | 24 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 29 | 19 | N/A | 9 | 1 |
| 12/31/2025 | 28 | 19 | N/A | 9 | 1 |
| 12/31/2024 | 23 | 27 | N/A | 5 | 1 |
| 6/30/2024 | 20 | 20 | 3 | 4 | N/A |
| 3/31/2024 | 20 | 13 | 5 | 5 | N/A |
| 12/31/2023 | 19 | 7 | 5 | 5 | N/A |
| 9/30/2023 | 18 | 13 | 7 | 7 | N/A |
| 6/30/2023 | 17 | 13 | 7 | 7 | N/A |
| 3/31/2023 | 16 | 18 | 5 | 5 | N/A |
| 12/31/2022 | 15 | 16 | 6 | 6 | N/A |
| 9/30/2022 | 14 | 21 | -4 | -4 | N/A |
| 6/30/2022 | 13 | 20 | -5 | -5 | N/A |
| 3/31/2022 | 11 | 16 | 25 | 3 | N/A |
| 12/31/2021 | 10 | 15 | 1 | 2 | N/A |
| 9/30/2021 | 7 | 3 | 5 | 11 | N/A |
| 6/30/2021 | 5 | 3 | 4 | 11 | N/A |
| 3/31/2021 | 3 | 2 | -27 | 3 | N/A |
| 12/31/2020 | 2 | 2 | -4 | 3 | N/A |
| 9/30/2020 | 2 | 44 | -2 | 0 | N/A |
| 6/30/2020 | 2 | 44 | 0 | 0 | N/A |
| 3/31/2020 | 2 | 43 | 0 | 0 | N/A |
| 12/31/2019 | 2 | 42 | 0 | 0 | N/A |
| 6/30/2019 | 1 | -1 | 1 | 1 | N/A |
| 3/31/2019 | 1 | -2 | 1 | 1 | N/A |
| 12/31/2018 | 2 | -3 | 1 | 1 | N/A |
| 9/30/2018 | 4 | -12 | 0 | 0 | N/A |
| 6/30/2018 | 4 | -17 | 0 | 0 | N/A |
| 3/31/2018 | 4 | -19 | N/A | 0 | N/A |
| 12/31/2017 | 3 | -21 | N/A | 1 | N/A |
| 9/30/2017 | 3 | -23 | N/A | 1 | N/A |
| 6/30/2017 | 3 | -24 | N/A | 1 | N/A |
| 3/31/2017 | 3 | -22 | N/A | 0 | N/A |
| 12/31/2016 | 3 | -20 | N/A | 0 | N/A |
| 9/30/2016 | 4 | -26 | N/A | -1 | N/A |
| 6/30/2016 | 3 | -20 | N/A | -2 | N/A |
| 3/31/2016 | 4 | -25 | N/A | -16 | N/A |
| 12/31/2015 | 4 | -24 | N/A | -16 | N/A |
| 9/30/2015 | 4 | -12 | N/A | -16 | N/A |
| 6/30/2015 | 4 | -10 | N/A | -15 | N/A |
| 3/31/2015 | 4 | -5 | N/A | -2 | N/A |
| 12/31/2014 | 4 | -6 | N/A | -1 | N/A |
| 9/30/2014 | 4 | -14 | N/A | -2 | N/A |
| 6/30/2014 | 5 | -15 | N/A | -3 | N/A |
| 3/31/2014 | 5 | -14 | N/A | -3 | N/A |
| 12/31/2013 | 5 | -15 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3FDA's earnings are forecast to decline over the next 3 years (-7.2% per year).
Earnings vs Market: 3FDA's earnings are forecast to decline over the next 3 years (-7.2% per year).
High Growth Earnings: 3FDA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 3FDA's revenue (15.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 3FDA's revenue (15.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3FDA's Return on Equity is forecast to be low in 3 years time (10.2%).